Clinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma

Clinical trial NCT07093073 · RECRUITING

Trial details

NCT number: NCT07093073
Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma

Start date: 2025-01-23
Primary completion: 2027-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.